Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)

Launched by AZIENDA OSPEDALIERO-UNIVERSITARIA CONSORZIALE POLICLINICO DI BARI · Jan 9, 2025

Keywords

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Moderate to severe erectile dysfunction (IIEF-5 score below 17)
• • Patients previously treated with first- and second-line therapies for ED
• • Patients who have undergone radical pelvic surgery with nerve sparing
• • Good pharmacological blood pressure control
• • Well-controlled diabetes on medication
• • Current or former smokers
• • Good renal function even with the use of medications
• • Well-controlled hypertriglyceridemia and/or hypercholesterolemia even with the use of medications
• • BMI less than or equal to 35
• • Normal levels of FSH, LH, PRL, Total Testosterone, and TSH
• Exclusion Criteria:
• • Patients on antidepressant, anxiolytic, sedative, or antipsychotic medications.
• • Consumers of more than 500 g of alcohol per day.
• • BMI greater than 35
• • Altered levels of FSH, LH, PRL, Total Testosterone, and TSH.